Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse Model

NEXT STORY
Gritstone Oncology to Present at Two Upcoming Investor Conferences in March
PREV STORY
OSE Immunotherapeutics Announces Clinical Trial Authorization for a Phase 1 by two Health Agencies (France and Belgium) to Evaluate the Selective SIRPα antagonist BI 765063* under Development in Collaboration with Boehringer Ingelheim in Patients with Advanced Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

author_avatar
NASDAQ Market News

CDPHP Offers Housing, Hope for Homeless Members

Albany, NY-based health insurer providers affordable housing for at-risk membersAlbany, NY, Dec. 21, 2018 ...

author_avatar
NASDAQ Market News

Vir Biotechnology to Present at Cantor Global Virtual Healthcare Conference

author_avatar
NASDAQ Market News